Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil

• Published in: Viruses 2022, Vol.14 (10)
• Main Authors: Slavov, Svetoslav Nanev, de La-Roque, Debora Glenda Lima, da Costa, Pericles Natan Mendes, Rodrigues, Evandra Strazza, Santos, Elaine Vieira, Borges, Josiane Serrano, Evaristo, Mariane, de Matos Maçonetto, Juliana, Marques, Adriana Aparecida, Milhomens, Jonathan, Rós, Felipe Augusto, Fonseca, Vagner, Lima, Alex Ranieri Jerônimo, Ribeiro, Gabriela, Lima, Loyze Paola Oliveira de, Garibaldi, Pedro Manuel Marques, Ferreira, Natasha Nicos, Moraes, Glenda Renata, Marqueze, Elaine Cristina, Barros, Claudia Renata dos Santos, Ma, Coutinho, Luiz Lehmann, Calado, Rodrigo Tocantins, Borges, Marcos, Elias, Maria Carolina, Sampaio, Sandra Coccuzzo, Giovanetti, Marta, Alcantara, Luiz Carlos Junior, Covas, Dimas Tadeu, Kashima, Simone
• Format: Report
• Language: English
• Subjects: Brazil; Epidemics; Health aspects; Medical research; Medicine, Experimental; Physiological aspects; Vaccination
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v14102148

From a country with one of the highest SARS-CoV-2 morbidity and mortality rates, Brazil has implemented one of the most successful vaccination programs. Brazil’s first model city vaccination program was performed by the CoronaVac vaccine (Sinovac Biotech) in the town of Serrana, São Paulo State. To evaluate the vaccination effect on the SARS-CoV-2 molecular dynamics and clinical outcomes, we performed SARS-CoV-2 molecular surveillance on 4375 complete genomes obtained between June 2020 and April 2022 in this location. This study included the period between the initial SARS-CoV-2 introduction and during the vaccination process. We observed that the SARS-CoV-2 substitution dynamics in Serrana followed the viral molecular epidemiology in Brazil, including the initial identification of the ancestral lineages (B.1.1.28 and B.1.1.33) and epidemic waves of variants of concern (VOC) including the Gamma, Delta, and, more recently, Omicron. Most probably, as a result of the immunization campaign, the mortality during the Gamma and Delta VOC was significantly reduced compared to the rest of Brazil, which was also related to lower morbidity. Our phylogenetic analysis revealed the evolutionary history of the SARS-CoV-2 in this location and showed that multiple introduction events have occurred over time. The evaluation of the COVID-19 clinical outcome revealed that most cases were mild (88.9%, 98.1%, 99.1% to Gamma, Delta, and Omicron, respectively) regardless of the infecting VOC. In conclusion, we observed that vaccination was responsible for reducing the death toll rate and related COVID-19 morbidity, especially during the gamma and Delta VOC; however, it does not prevent the rapid substitution rate and morbidity of the Omicron VOC.